Kevin Rodriguez+FollowModerna’s RSV Shot Just Got a Big BoostModerna’s RSV vaccine just scored FDA approval for younger adults (18-59) with health issues—previously, it was only for those 60+. The move comes as RSV risks for under-60s are often overlooked, but a ton of people in that group have conditions that put them at risk. Meanwhile, vaccine policy is getting a shake-up with RFK Jr. bringing in new advisors (some anti-vax!), and Moderna’s stock is feeling the heat. Big pharma drama and health news all in one! #Moderna #RSV #FDA #Health #BodyHealth90Share
nheath+FollowRSV Hospitalizations Dropped Big Time!Did you hear? Babies are getting way less sick from RSV this year! Thanks to new RSV vaccines for pregnant moms and a shot called nirsevimab for newborns, hospitalizations for infants dropped by up to 52%. That’s a huge win for new parents—especially during those scary winter months. If you know anyone expecting or with a newborn, this is definitely worth sharing! #RSV #ParentingTips #HealthNews #VaccinesWork #BabyHealth #Health00Share
Caleb Richmond+FollowRSV Shots Now for 50+? Here’s What’s New!Just spotted some big news for anyone 50 and up: CDC advisers say RSV shots should be available for at-risk folks as young as 50 (down from 60+)! That could help so many who worry about catching RSV, which can get pretty serious. Plus, they’re still figuring out the best timing for boosters and looking at more data. Would you get the shot if recommended? Let’s talk! #RSV #HealthUpdate #Vaccines #CDC #StayHealthy #Health60Share
